Abstract
In this scoping review, we sought to summarize the types of outcomes collected in pregnant patients with ankylosing spondylitis (AS), and to identify some methodological limitations related to pregnancy research in these patients. A comprehensive search was done to identify relevant articles in MEDLINE and Embase. We included 21 studies assessing pregnancy outcomes in AS. Most studies reported disease flare during pregnancy, and few reported improved disease activity or stable disease. Disease flare occurred in 25–80% of patients during pregnancy and in 30–100% during the postpartum. There was no increased risk of pre-eclampsia across all studies. Based on two case-control studies, there was an increased risk for prematurity and small for gestational age in AS pregnancies, pooled odds ratio (95% confidence interval) 1.99 (1.30–3.05) and 2.41 (1.22–4.77), respectively. The etiologies of cesarean section were not related to joint issues from AS but were related to other causes like pre-eclampsia and prematurity. Some key methodological issues were related to the study design, selection of study participants, disease classification, choice of control participants, and outcome measures. Based on the current literature review, some key areas for future research should evaluate the disease state at conception, effects of pharmacological treatment for AS during pregnancy, and long-term outcomes of children born to women with AS. The use of pregnancy registers and validated measurement tools in pregnancy will help to improve the state and quality of evidence in this field.
Key Points • Disease flare during pregnancy in patients with ankylosing spondylitis (AS) occurred in 25–80% of the cases in the various studies, and in 30–100% of the cases during the postpartum period. • There was an increased risk for prematurity, and no increased risk of pre-eclampsia or small for gestational age. Etiologies of cesarean section were not related to the hip or sacroiliac joint affection of the disease but to other causes like pre-eclampsia and prematurity. • This study provides a comprehensive overview of issues related to research on pregnant women with ankylosing spondylitis (AS). We addressed methodological issues related to the study design, selection of study participants, disease classification, control choice, assessment of outcomes measures, and statistical analysis. • The use of pregnancy registers and validated disease activity measurement tools for pregnancy can enhance pregnancy research in women with AS. |
Similar content being viewed by others
References
Zochling J, Smith EU (2010) Seronegative spondyloarthritis. Best practice and research. Clin Rheumatol 24(6):747–756. https://doi.org/10.1016/j.berh.2011.02.002
Park EH, Jun JK, Lee SM, Song YW, Lee EB (2017) Pregnancy outcomes in Korean women with ankylosing spondylitis. Ann Rheum Dis 76(Supplement 2):922–923. https://doi.org/10.1136/annrheumdis-2017-eular.2511
Sammaritano LR (2013) Pregnancy in rheumatic disease patients. J Clin Rheumatol 19(5):259–266. https://doi.org/10.1097/RHU.0b013e31829ce35f
Keeling SO, Oswald AE (2009) Pregnancy and rheumatic disease: “by the book” or “by the doc”. Clin Rheumatol 28(1):1–9. https://doi.org/10.1007/s10067-008-1031-9
Lui NL, Haroon N, Carty A, Shen H, Cook RJ, Shanmugarajah S, Gladman DD, Inman RD (2011) Effect of pregnancy on ankylosing spondylitis: a case-control study. J Rheumatol 38(11):2442–2444. https://doi.org/10.3899/jrheum.101174
Ostensen M, Husby G (1984) Pregnancy and rheumatic disease. A review of recent studies in rheumatoid arthritis and ankylosing spondylitis. Klin Wochenschr 62(19):891–895
Ostensen M, Husby G (1983) A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 26(9):1155–1159. https://doi.org/10.1002/art.1780260915
Zhou Q, Bian XM, Liu JT (2012) Management of pregnancy with ankylosing spondylitis. Chin Med Sci J 27(1):46–49
Förger F, Østensen M, Schumacher A, Villiger PM (2005) Impact of pregnancy on health related quality of life evaluated prospectively in pregnant women with rheumatic diseases by the SF-36 health survey. Ann Rheum Dis 64(10):1494–1499. https://doi.org/10.1136/ard.2004.033019
Förger F, Villiger PM, Ostensen M (2009) Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role? Arthritis Rheum 61(2):279–283. https://doi.org/10.1002/art.24161
Ostensen M, Romberg O, Husby G (1982) Ankylosing spondylitis and motherhood. Arthritis Rheum 25(2):140–143
Timur H, Tokmak A, Türkmen GG, Ali İnal H, Uygur D, Danışman N (2016) Pregnancy outcome in patients with ankylosing spondylitis. J Matern Fetal Neonatal Med 29(15):2470–2474. https://doi.org/10.3109/14767058.2015.1089432
Ursin K, Lydersen S, Skomsvoll JF, Wallenius M (2018) Disease activity during and after pregnancy in women with axial spondyloarthritis: a prospective multicentre study. Rheumatology 57(6):1064–1071. https://doi.org/10.1093/rheumatology/key047
Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE (2018) Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep 20(6):35. https://doi.org/10.1007/s11926-018-0744-2
Robinson PC, Sengupta R, Siebert S (2019) Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging and therapy. Rheumatol Ther 6(2):165–177. https://doi.org/10.1007/s40744-019-0146-6
Lindström U, Olofsson T, Wedrén S, Qirjazo I, Askling J (2019) Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice. Arthritis Res Ther 21(1):128. https://doi.org/10.1186/s13075-019-1908-9
Munn Z, Porritt K, Lockwood C, Aromataris E, Pearson A (2014) Establishing confidence in the output of qualitative research synthesis: the ConQual approach. BMC Med Res Methodol 14:108–108. https://doi.org/10.1186/1471-2288-14-108
Pearson A, Jordan Z, Munn Z (2012) Translational science and evidence-based healthcare: a clarification and reconceptualization of how knowledge is generated and used in healthcare. Nurs Res Pract 2012:792519–792516. https://doi.org/10.1155/2012/792519
Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E (2018) Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol 18(1):143. https://doi.org/10.1186/s12874-018-0611-x
Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8(1):19–32. https://doi.org/10.1080/1364557032000119616
Jakobsson GL, Stephansson O, Askling J, Jacobsson LT (2016) Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study. Ann Rheum Dis 75(10):1838–1842. https://doi.org/10.1136/annrheumdis-2015-207992
Mørk S, Voss A, Möller S, Bliddal M (2019) Spondyloarthritis and outcomes in pregnancy and labor: a nationwide register‐based cohort study. Arthritis Care Res:23. https://doi.org/10.1002/acr.24111
Park EH, Lee JS, Kim YJ, Lee SM, Jun JK, Lee EB, Kim YG (2019) Pregnancy outcomes in Korean women with ankylosing spondylitis. Korean J Intern Med 26. https://doi.org/10.3904/kjim.2019.144
Ostensen M, von Schoultz B, Husby G (1983) Comparison between serum alpha 2-pregnancy-associated globulin and activity of rheumatoid arthritis and ankylosing spondylitis during pregnancy. Scand J Rheumatol 12(3):315–318
Ostensen M (1984) The influence of pregnancy on blood parameters in patients with rheumatic disease. Scand J Rheumatol 13(3):203–208
Ostensen M, Ostensen H (1998) Ankylosing spondylitis--the female aspect. J Rheumatol 25(1):120–124
Østensen M, Fuhrer L, Mathieu R, Seitz M, Villiger PM (2004) A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis 63(10):1212–1217. https://doi.org/10.1136/ard.2003.016881
Østensen M, Förger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM (2005) Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 64(6):839–844
Davutoğlu EA, Ozel A, Yılmaz N, Madazli R (2017) Pregnancy outcome in 162 women with rheumatic diseases: experience of a university hospital in Turkey. Arch Gynecol Obstet 296(6):1079–1084. https://doi.org/10.1007/s00404-017-4535-1
van den Brandt S, Zbinden A, Baeten D, Villiger PM, Østensen M, Förger F (2017) Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther 19(1):64. https://doi.org/10.1186/s13075-017-1269-1
Zbinden A, van den Brandt S, Østensen M, Villiger PM, Förger F (2018) Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology 57(7):1235–1242. https://doi.org/10.1093/rheumatology/key053
Smith CJF, Bandoli G, Kavanaugh A, Chambers CD (2019) Birth outcomes and disease activity during pregnancy in a prospective cohort of women with psoriatic arthritis and ankylosing spondylitis. Arthritis Care Res 10:1029–1037. https://doi.org/10.1002/acr.23924
Unal C, Fadiloglu E, Tanacan A, Zaim OC, Beksac MS (2020) Retrospective evaluation of pregnancies with ankylosing spondylitis in a tertiary center in Turkey. Int J Rheum Dis 23(1):101–105. https://doi.org/10.1111/1756-185X.13746
Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2019) Handbook for Systematic Reviews of Interventions version 6.0 Available from http://www.training.cochrane.org/handbook
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC (2011) Cochrane bias methods group, Cochrane statistical methods group. BMJ 343:d5928–d5928. https://doi.org/10.1136/bmj.d5928
Wells GA, Tugwell P, O’Connell D, Welch V, Peterson J, Shea B, Losos M (2015) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358:j4008. https://doi.org/10.1136/bmj.j4008
Molto A, Gensler L, Clowse MEB, Marzo-Ortega H, Artignan A, Goff-Leggett D, Leonard S, Resemann HK, Thurtle E, De Peyrecave N, Ecoffet C, Forger F (2018) Pregnancy outcomes and disease activity in women with axial spondyloarthritis: a systematic literature review. Ann Rheum Dis 77(Supplement 2):340–341. https://doi.org/10.1136/annrheumdis-2018-eular.3056
Krishna G, Shajpal A, Divall P, Khare M, Moorthy A (2019) A systematic review of pregnancy outcome in ankylosing spondylitis. Ann Rheum Dis 78(Supplement 2):479. https://doi.org/10.1136/annrheumdis-2019-eular.5002
Giovannopoulou E, Gkasdaris G, Kapetanakis S, Kontomanolis E (2017) Ankylosing spondylitis and pregnancy: a literature review. Curr Rheumatol Rev 13(3):162–169. https://doi.org/10.2174/1573397113666170317114857
Gandaloeva Z, Krichevskaya O, Dubinina T (2019) Drug therapy of ankylosing spondylitis (as) during pregnancy in real clinical practice. Ann Rheum Dis 78(Supplement 2):880. https://doi.org/10.1136/annrheumdis-2019-eular.6750
Crisafulli F, Andreoli L, Gerardi MC, Fernandez AG, Nalli C, Filippini M, Gorla R, Taglietti M, Fredi M, Lazzaroni MG, Lojacono A, Zatti S, Franceschini F, Tincani A (2019) Disease course and outcomes during pregnancy in patients with axial spondiloarthritis: comparison between TNFi users and naive patients. Ann Rheum Dis 78(Supplement 2):878. https://doi.org/10.1136/annrheumdis-2019-eular.7705
Levy RA, Vilela VS, Cataldo MJ, Ramos RC, Duarte JL, Tura BR, Albuquerque EM, Jesús NR (2001) Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10(6):401–404. https://doi.org/10.1191/096120301678646137
Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDougall J (2000) Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 183(4):1008–1012. https://doi.org/10.1067/mob.2000.106754
Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D’Anci KE (2020) American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72:529–556. https://doi.org/10.1002/art.41191
Song JW, Chung KC (2010) Observational studies: cohort and case-control studies. Plast Reconstr Surg 126(6):2234–2242. https://doi.org/10.1097/PRS.0b013e3181f44abc
Burns PB, Rohrich RJ, Chung KC (2011) The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 128(1):305–310. https://doi.org/10.1097/PRS.0b013e318219c171
Mann CJ (2003) Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J 20(1):54–60. https://doi.org/10.1136/emj.20.1.54
Mazzali C, Paganoni AM, Ieva F, Masella C, Maistrello M, Agostoni O, Scalvini S, Frigerio M, Data Project HF, on behalf of the HFDP (2016) Methodological issues on the use of administrative data in healthcare research: the case of heart failure hospitalizations in Lombardy region, 2000-2012. BMC Health Serv Res 16(1):234. https://doi.org/10.1186/s12913-016-1489-0
Gavrielov-Yusim N, Friger M (2014) Use of administrative medical databases in population-based research. J Epidemiol Community Health 68(3):283–287. https://doi.org/10.1136/jech-2013-202744
Vinet E, Chakravarty EF, Simard JF, Clowse M (2018) Use of administrative databases to assess reproductive health issues in rheumatic diseases. Rheum Dis Clin N Am 44(2):327–336. https://doi.org/10.1016/j.rdc.2018.01.008
Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783. https://doi.org/10.1136/ard.2009.108233
Malay S, Chung KC (2012) The choice of controls for providing validity and evidence in clinical research. Plast Reconstr Surg 130(4):959–965. https://doi.org/10.1097/PRS.0b013e318262f4c8
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A (2016) Physiological changes in pregnancy. Cardiovasc J Afr 27(2):89–94. https://doi.org/10.5830/CVJA-2016-021
MacLean MA, Wilson R, Thomson JA, Krishnamurthy S, Walker JJ (1992) Immunological changes in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 43(3):167–172. https://doi.org/10.1016/0028-2243(92)90169-y
Chen D, Lao M, Zhang J, Zhan Y, Li W, Cai X, Zhan Z (2018) Fetal and maternal outcomes of planned pregnancy in patients with systemic lupus erythematosus: a retrospective multicenter study. J Immunol Res 2018:2413637–2413637. https://doi.org/10.1155/2018/2413637
Warren RB, Reich K, Langley RG, Strober B, Gladman D, Deodhar A, Bachhuber T, Bao W, Altemeyer E, Hussain S, Safi J (2018) Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database. Br J Dermatol 179(5):1205–1207. https://doi.org/10.1111/bjd.16901
Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F (2018) Pregnancy outcomes after exposure to certolizumab pegol: updated results from a pharmacovigilance safety database. Arthritis Rheumatol 70(9):1399–1407. https://doi.org/10.1002/art.40508
Meissner Y, Fischer-Betz R, Andreoli L, Costedoat-Chalumeau N, De Cock D, Dolhain R, Forger F, Goll D, Molto A, Ozdemir R, Raio L, Nelson-Piercy C, Rodriguez-Garcia SC, Sciascia S, Wallenius M, Zbinden A, Zink A, Strangfeld A (2019) Development of a standardized minimal core data set for pregnancy registers in rheumatology - results of a EULAR task force. Ann Rheum Dis 78(Supplement 2):246. https://doi.org/10.1136/annrheumdis-2019-eular.4021
Meissner Y, Strangfeld A, Costedoat-Chalumeau N, Forger F, Molto A, Wallenius M, Fischer-Betz R (2018) Defining a standardized core data set for pregnancy registers in rheumatic diseases-an European approach. Arthritis Rheumatol 70(Supplement 9):2684–2685. https://doi.org/10.1002/art.40700
Eudy AM, Petri M, Fischer-Betz R, Mokbel A, Nalli C, Andreoli L, Tincani A, Molad Y, Gladman D, Urowitz M, Balevic S, Clowse ME (2018) CS−03 hydroxychloroquine in lupus pregnancy: a meta-analysis of individual participant data. Lupus Sci Med 5(Supplement 2):A21. https://doi.org/10.1136/lupus-2018-lsm.38
Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D’Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patanè M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scirè CA, Tincani A (2019) Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. Autoimmun Rev 18(2):164–176. https://doi.org/10.1016/j.autrev.2018.08.008
Acknowledgments
We thank Malak Maaraba (medical student) and Dr. Sherif Gamal for their work as second reviewers and in extracting the data. We are indebted to Dr. Megan Clowse for discussing the main concepts of the review and for her valuable remarks.
Author information
Authors and Affiliations
Contributions
Abir Mokbel: study conception, protocol writing, search, screening and data extraction, analysis, writing of the manuscript. Daeria O. Lawson: critical revision of the methodology, writing of the manuscript. Forough Farrokhyar: protocol revision. All the authors were involved in the critical revision of the manuscript and approved the final version.
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 32 kb)
Rights and permissions
About this article
Cite this article
Mokbel, A., Lawson, D.O. & Farrokhyar, F. Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review. Clin Rheumatol 40, 3465–3480 (2021). https://doi.org/10.1007/s10067-021-05588-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-021-05588-9